Anne M. Hagemeijer

Anne M. Hagemeijer's AcademicInfluence.com Rankings

Anne M. Hagemeijer

Medical

#2540

World Rank

#2968

Historical Rank

Oncology

#160

World Rank

#166

Historical Rank

medical Degrees

Download Badge

Medical

Why Is Anne M. Hagemeijer Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Anne M. Hagemeijer's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia (1982) (1354)
KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours. (2006) (836)
Acquired mutations in TET2 are common in myelodysplastic syndromes (2009) (747)
The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. (1999) (718)
Translocation of c-abl oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia (1983) (715)
Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype. (2008) (566)
Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants. (2005) (484)
Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group. (2004) (449)
Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia (2004) (432)
Can, a putative oncogene associated with myeloid leukemogenesis, may be activated by fusion of its 3' half to different genes: characterization of the set gene (1992) (409)
Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial. (2003) (368)
Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party. Groupe Français de Cytogénétique Hématologique, Groupe de Français d'Hematologie Cellulaire, UK Cancer Cytogenetics Group and BIOMED 1 European Community-Concerted Action "Mole (2000) (333)
Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: from thymocyte to lymphoblast (2006) (290)
Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and (1998) (271)
Gemtuzumab Ozogamicin Versus Best Supportive Care in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Unsuitable for Intensive Chemotherapy: Results of the Randomized Phase III EORTC-GIMEMA AML-19 Trial. (2016) (270)
Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large‐cell lymphoma and inflammatory myofibroblastic tumor (2002) (269)
Myeloid cell differentiation arrest by miR-125b-1 in myelodysplasic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation (2008) (266)
Translocation (12;22) (p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11. (1995) (241)
Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity (2004) (210)
Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). (2007) (205)
A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy (2012) (198)
Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias (2004) (178)
A new morphologic classification system for acute promyelocytic leukemia distinguishes cases with underlying PLZF/RARA gene rearrangements. (2000) (173)
Hu-ets-1 and Hu-ets-2 genes are transposed in acute leukemias with (4;11) and (8;21) translocations. (1986) (171)
Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951. (2004) (168)
Predominance of functional multidrug resistance (MDR-1) phenotype in CD34+ acute myeloid leukemia cells. (1993) (166)
Diagnosis of acute promyelocytic leukaemia by RT‐PCR: detection of PML‐RARA and RARA‐PML fusion transcripts (1992) (165)
Is the chromosomal region 9q34 always involved in variants of the Ph1 translocation? (1984) (156)
FOXP1, a gene highly expressed in a subset of diffuse large B-cell lymphoma, is recurrently targeted by genomic aberrations (2005) (153)
Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDS. (2001) (153)
Fusion of EML1 to ABL1 in T-cell acute lymphoblastic leukemia with cryptic t(9;14)(q34;q32). (2005) (149)
Fusion of ETV6 to MDS1/EVI1 as a result of t(3;12)(q26;p13) in myeloproliferative disorders. (1997) (148)
Translocation (9;11)(p21;q23) in three cases of acute monoblastic leukemia. (1982) (147)
High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trial. (2014) (147)
Expression analyses identify MLL as a prominent target of 11q23 amplification and support an etiologic role for MLL gain of function in myeloid malignancies. (2004) (142)
bcr rearrangement and translocation of the c-abl oncogene in Philadelphia positive acute lymphoblastic leukemia (1986) (138)
Multiple rearranged immunoglobulin genes in childhood acute lymphoblastic leukemia of precursor B-cell origin. (1991) (137)
Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas. (1994) (135)
Cytogenetic follow-up of patients with nonlymphocytic leukemia. II. Acute nonlymphocytic leukemia. (1981) (134)
The t(10;11) translocation in acute myeloid leukemia (M5) consistently fuses the leucine zipper motif of AF10 onto the HRX gene. (1995) (130)
The breakpoint region of the most common isochromosome, i(17q), in human neoplasia is characterized by a complex genomic architecture with large, palindromic, low-copy repeats. (2004) (130)
Characteristic pattern of chromosomal gains and losses in marginal zone B cell lymphoma detected by comparative genomic hybridization (1997) (130)
FLT3 and MLL intragenic abnormalities in AML reflect a common category of genotoxic stress. (2003) (124)
A new recurrent inversion, inv(7)(p15q34), leads to transcriptional activation of HOXA10 and HOXA11 in a subset of T-cell acute lymphoblastic leukemias (2005) (124)
MYC-containing double minutes in hematologic malignancies: evidence in favor of the episome model and exclusion of MYC as the target gene. (2006) (121)
Establishment and characterization of 7 ovarian carcinoma cell lines and one granulosa tumor cell line: Growth features and cytogenetics (1993) (120)
Human antigen and enzyme markers in man-Chinese hamster somatic cell hybrids: evidence for synteny between the HL-A, PGM3, ME1, and IPO-B loci. (1974) (117)
Improved identification of chromosomes of leukemic cells in methotrexate-treated cultures. (1979) (116)
A collaborative study of the relationship of the morphological type of acute nonlymphocytic leukemia with patient age and karyotype. (1982) (115)
ALK‐ATIC fusion in urinary bladder inflammatory myofibroblastic tumor (2003) (113)
The translocations, t(11;19)(q23;p13.1) and t(11;19)(q23;p13.3): a cytogenetic and clinical profile of 53 patients (1998) (113)
Recurrent rearrangement of the Ewing's sarcoma gene, EWSR1, or its homologue, TAF15, with the transcription factor CIZ/NMP4 in acute leukemia. (2002) (111)
Frequent occurrence of BCL6 rearrangements in nodular lymphocyte predominance Hodgkin lymphoma but not in classical Hodgkin lymphoma. (2003) (111)
Long‐term survival of patients with acute myeloid leukemia (1997) (111)
Isochromosome 17q in blast crisis of chronic myeloid leukemia and in other hematologic malignancies is the result of clustered breakpoints in 17p11 and is not associated with coding TP53 mutations. (1999) (110)
The 11q;22q translocation: A European collaborative analysis of 43 cases (2004) (109)
Establishment and characterization of primary and metastatic uveal melanoma cell lines (1996) (104)
Translocation of BCR to chromosome 9: A new cytogenetic variant detected by FISH in two Ph‐negative, BCR‐positive patients with chronic myeloid leukemia (1993) (104)
Richter's syndrome with different immunoglobulin light chains and different heavy chain gene rearrangements. (1984) (103)
Cytogenetic analysis of malignant mesothelioma. (1990) (100)
The leukemic fusion gene AML1-MDS1-EVI1 suppresses CEBPA in acute myeloid leukemia by activation of Calreticulin. (2004) (99)
Cytogenetic profile of lymphoma of follicle mantle lineage: correlation with clinicobiologic features. (1999) (98)
Expression of c-sis (PDGF B-chain) and PDGF A-chain genes in ten human malignant mesothelioma cell lines derived from primary and metastatic tumors. (1988) (98)
The cryptic inv(2)(p23q35) defines a new molecular genetic subtype of ALK-positive anaplastic large-cell lymphoma. (1998) (97)
Fluorescence in situ hybridization study of chromosome 7 aberrations in hepatosplenic T‐cell lymphoma: Isochromosome 7q as a common abnormality accumulating in forms with features of cytologic progression (2002) (97)
Differential expression of KIT/PDGFRA mutant isoforms in epithelioid and mixed variants of gastrointestinal stromal tumors depends predominantly on the tumor site (2004) (96)
Human malignant mesothelioma cell lines express PDGF beta-receptors whereas cultured normal mesothelial cells express predominantly PDGF alpha-receptors. (1991) (94)
Translocations t(11;18)(q21;q21) and t(14;18)(q32;q21) are the main chromosomal abnormalities involving MLT/MALT1 in MALT lymphomas (2003) (93)
A novel gene, MSI2, encoding a putative RNA-binding protein is recurrently rearranged at disease progression of chronic myeloid leukemia and forms a fusion gene with HOXA9 as a result of the cryptic t(7;17)(p15;q23). (2002) (92)
Detection of t(11;18)(q21;q21) by interphase fluorescence in situ hybridization using API2 and MLT specific probes. (2000) (92)
Fusion of a novel gene, BTL, to ETV6 in acute myeloid leukemias with a t(4;12)(q11-q12;p13). (1999) (92)
The translocation (6;9) (p23;q34) shows consistent rearrangement of two genes and defines a myeloproliferative disorder with specific clinical features (1992) (91)
Replication pattern of the X chromosomes in three X/autosomal translocations. (1977) (91)
The gene for the cyclin‐dependent‐kinase‐4 inhibitor, CDKN2A, is preferentially deleted in malignant mesothelioma (1998) (89)
t(5;14)/HOX11L2-positive T-cell acute lymphoblastic leukemia. A collaborative study of the Groupe Français de Cytogénétique Hématologique (GFCH) (2003) (89)
Prognostic significance of the balanced t(1;19) and unbalanced der(19)t(1;19) translocations in acute lymphoblastic leukemia. (1992) (89)
Evidence for position effects as a variant ETV6-mediated leukemogenic mechanism in myeloid leukemias with a t(4;12)(q11-q12;p13) or t(5;12)(q31;p13). (2002) (89)
Abnormalities of the short arm of chromosome 9 with partial loss of material in hematological disorders. (1987) (89)
Breakpoint heterogeneity in t(10;11) translocation in AML-M4/M5 resulting in fusion of AF10 and MLL is resolved by fluorescent in situ hybridization analysis. (1995) (87)
Sequence conservation of the rad21 Schizosaccharomyces pombe DNA double-strand break repair gene in human and mouse. (1996) (87)
Molecular cytogenetic study of 126 unselected T-ALL cases reveals high incidence of TCRβ locus rearrangements and putative new T-cell oncogenes (2006) (85)
Sequential administration of gemtuzumab ozogamicin and conventional chemotherapy as first line therapy in elderly patients with acute myeloid leukemia: a phase II study (AML-15) of the EORTC and GIMEMA leukemia groups. (2004) (83)
Chromosomal translocations independently predict treatment failure, treatment-free survival and overall survival in B-cell chronic lymphocytic leukemia patients treated with cladribine (2007) (82)
Acute myeloid leukemia M4 with bone marrow eosinophilia (M4Eo) and inv(16)(p13q22) exhibits a specific immunophenotype with CD2 expression (1993) (81)
bcr-abl oncogene activation in Philadelphia chromosome-positive acute lymphoblastic leukemia. (1988) (81)
Translocation of c-abl to "masked" Ph in chronic myeloid leukemia. (1985) (80)
Proposals for standardized protocols for cytogenetic analyses of acute leukemias, chronic lymphocytic leukemia, chronic myeloid leukemia, chronic myeloproliferative disorders, and myelodysplastic syndromes (2007) (78)
Detection of CBP rearrangements in acute myelogenous leukemia with t(8;16) (1997) (78)
Histologic Localization of PLAG1 (Pleomorphic Adenoma Gene 1) in Pleomorphic Adenoma of the Salivary Gland: Cytogenetic Evidence of Common Origin of Phenotypically Diverse Cells (2001) (78)
Decitabine improves progression-free survival in older high-risk MDS patients with multiple autosomal monosomies: results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group (2015) (77)
Hyaline vascular Castleman's disease with HMGIC rearrangement in follicular dendritic cells: molecular evidence of mesenchymal tumorigenesis. (2002) (77)
Lymphocyte predominance Hodgkin disease is characterized by recurrent genomic imbalances. (2001) (76)
Review of clinical, cytogenetic, and molecular aspects of Ph-negative CML. (1991) (75)
The 5q‐ chromosome abnormality in haematological disorders:|a collaborative study of 34 cases from the Netheralands (1982) (75)
Genetic abnormalities in marginal zone B‐cell lymphoma (2000) (74)
Karyotypically distinct subpopulations in acute leukemia with specific growth requirements. (1982) (74)
t(14;19)/BCL3 rearrangements in lymphoproliferative disorders: a review of 23 cases. (1997) (74)
Value of allogeneic versus autologous stem cell transplantation and chemotherapy in patients with myelodysplastic syndromes and secondary acute myeloid leukemia. Final results of a prospective randomized European Intergroup Trial (2010) (72)
PHA-induced colony formation in acute non-lymphocytic and chronic myeloid leukemia. (1980) (71)
t(6;8), t(8;9) and t(8;13) translocations associated with stem cell myeloproliferative disorders have close or identical breakpoints in chromosome region 8p11-12 (1998) (71)
Extensive cross-homology between the long and the short arm of chromosome 16 may explain leukemic inversions and translocations. (1992) (70)
Translocation (8;21)(q22;q22) in Acute Nonlymphocytic Leukemia (1984) (70)
Cytogenetic studies of 103 patients with acute myelogenous leukemia in relapse. (1989) (70)
Translocation t(6;9) in acute non-lymphocytic leukaemia results in the formation of a DEK-CAN fusion gene. (1992) (69)
Rapid detection of chromosome 16 inversion in acute nonlymphocytic leukemia, subtype M4: regional localization of the breakpoint in 16p. (1990) (69)
Expression of the mdr3 gene in prolymphocytic leukemia: Association with cyclosporin‐a‐induced increase in drug accumulation (1990) (69)
Fluorescence in situ hybridization characterization of new translocations involving TEL (ETV6) in a wide spectrum of hematologic malignancies. (1998) (69)
Clear cell sarcoma of the stomach (2002) (68)
Secondary chromosome changes in mantle cell lymphoma. (1999) (68)
bcr rearrangement and translocation of the c-abl oncogene in Philadelphia positive acute lymphoblastic leukemia. (1986) (68)
Localization of the human c-sis oncogene in Ph1-positive and Ph1- negative chronic myelocytic leukemia by in situ hybridization (1984) (67)
Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia (2009) (67)
The stem cell mobilizing capacity of patients with acute myeloid leukemia in complete remission correlates with relapse risk: results of the EORTC-GIMEMA AML-10 trial (2003) (67)
Cutaneous sclerosing perineurioma with cryptic NF2 gene deletion. (1999) (65)
A new disease categorization of low-grade myelodysplastic syndromes based on the expression of cytopenia and dysplasia in one versus more than one lineage improves on the WHO classification (2007) (65)
Cloning, comparative mapping, and RNA expression of the mouse homologues of the Saccharomyces cerevisiae nucleotide excision repair gene RAD23. (1996) (65)
Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL+ leukemias: incidence and underlying genetic abnormalities (2003) (64)
Inhibition of the growth of cultured human meningioma cells by recombinant interferon-alpha. (1991) (63)
Cytogenetic and molecular analysis in Philadelphia negative CML. (1989) (63)
Expression of human myeloid-associated surface antigens in human-mouse myeloid cell hybrids. (1983) (62)
Rare recurring balanced chromosome abnormalities in therapy‐related myelodysplastic syndromes and acute leukemia: Report from an International Workshop † (2002) (62)
In situ hybridization on May-Grünwald Giemsa-stained bone marrow and blood smears of patients with hematologic disorders allows detection of cell-lineage-specific cytogenetic abnormalities. (1993) (62)
Cytogenetic analysis of Barrett's mucosa and adenocarcinoma of the distal esophagus and cardia. (1996) (62)
RT-PCR diagnosis of patients with acute nonlymphocytic leukemia and inv(16)(p13q22) and identification of new alternative splicing in CBFB-MYH11 transcripts. (1995) (60)
Structure, chromosome localization, and regulation of expression of the interferon-regulated mouse Ifi54/Ifi56 gene family. (1994) (60)
Characterization of the blast cells in acute leukemia with translocation (4;11): report of eight additional cases and of one case with a variant translocation. (1987) (60)
High expression of the multidrug resistance P-glycoprotein in high-risk myelodysplasia is associated with immature phenotype. (1993) (59)
ABL1 rearrangements in T‐Cell acute lymphoblastic leukemia (2010) (59)
Expression of the wilms' tumor gene WT1 in human malignant mesothelioma cell lines and relationship to platelet‐derived growth factor A and insulin‐like growth factor 2 expression (1995) (59)
CDKN2 deletions have no prognostic value in childhood precursor-B acute lymphoblastic leukaemia (2005) (58)
EVI1 is consistently expressed as principal transcript in common and rare recurrent 3q26 rearrangements (2006) (58)
A t(4;22) in a meningioma points to the localization of a putative tumor-suppressor gene. (1991) (58)
BCL6 gene rearrangements also occur in marginal zone B‐cell lymphoma (1997) (58)
Localization of two human homologs, HHR6A and HHR6B, of the yeast DNA repair gene RAD6 to chromosomes Xq24-q25 and 5q23-q31. (1992) (58)
Establishment of human malignant mesothelioma cell lines (1989) (56)
Comparative genomic hybridization pattern distinguishes T-cell/histiocyte-rich B-cell lymphoma from nodular lymphocyte predominance Hodgkin's lymphoma. (2002) (56)
A novel variant of the bcr-abl fusion product in Philadelphia chromosome-positive acute lymphoblastic leukemia. (1990) (56)
Chronic lymphocytic leukemia and prolymphocytic leukemia with MYC translocations: a subgroup with an aggressive disease course (2012) (55)
Translocation 1;7 in dyshematopoiesis: possibly induced with a nonrandom geographic distribution. (1984) (55)
Improved detection of chromosomal abnormalities in chronic lymphocytic leukemia by conventional cytogenetics using CpG oligonucleotide and interleukin‐2 stimulation: A Belgian multicentric study (2009) (54)
Bone Marrow Karyotypes of Children with Nonlymphocytic Leukemia (1979) (54)
Chronic myeloid leukemia with permanent disappearance of the Ph1 chromosome and development of new clonal subpopulations. (1979) (54)
Cytogenetic clonality analysis in myelodysplastic syndrome: monosomy 7 can be demonstrated in the myeloid and in the lymphoid lineage. (1995) (53)
Additional prognostic value of bone marrow histology in patients subclassified according to the International Prognostic Scoring System for myelodysplastic syndromes. (2003) (52)
Circulating myeloid and lymphoid precursor dendritic cells are clonally involved in myelodysplastic syndromes (2004) (51)
Implementation of standardized international karyotype scoring practices is needed to provide uniform and systematic evaluation for patients with myelodysplastic syndrome using IPSS criteria: An International Working Group on MDS Cytogenetics Study. (2010) (50)
The recurrent translocation t(14;20)(q32;q12) in multiple myeloma results in aberrant expression of MAFB: a molecular and genetic analysis of the chromosomal breakpoint (2004) (49)
Randomized study on hydroxyurea alone versus hydroxyurea combined with low-dose interferon-alpha 2b for chronic myeloid leukemia. The Benelux CML Study Group. (1998) (48)
Sustained, clonal karyotype abnormalities in the Philadelphia chromosome negative cells of CML patients successfully treated with Imatinib (2003) (47)
Regional localization of the genes coding for human ACO2, ARSA, and NAGA on chromosome 22. (1980) (46)
bcr-abl mRNA lacking abl exon a2 detected by polymerase chain reaction in a chronic myelogeneous leukemia patient. (1991) (46)
Chromosomes in Acute Promyelocytic Leukemia (1984) (45)
Familial anaplastic ependymoma: evidence of loss of chromosome 22 in tumour cells. (1994) (45)
Acute myeloid leukemia colony growth in vitro: differences of colony-forming cells in PHA-supplemented and standard leukocyte feeder cultures. (1982) (45)
Tissue culture loss of aneuploid cells from carcinomas of the prostate (1993) (45)
Variant t(2;11)(p11;q13) associated with the IgK-CCND1 rearrangement is a recurrent translocation in leukemic small-cell B-non-Hodgkin lymphoma (2004) (45)
Concurrent activation of MYC and BCL2 in B cell non-Hodgkin lymphoma cell lines by translocation of both oncogenes to the same immunoglobulin heavy chain locus. (1996) (45)
Endometrial stromal sarcoma presenting as postpartum haemorrhage: report of a case with a sole t(10;17)(q22;p13) translocation. (2003) (44)
Interstitial del(14)(q) involving IGH: a novel recurrent aberration in B-NHL (2007) (44)
Fluorescence in situ hybridization for the detection and monitoring of the Ph-positive clone in chronic myelogenous leukemia: comparison with metaphase banding analysis (1998) (44)
Adult sclerosing rhabdomyosarcoma: cytogenetic link with embryonal rhabdomyosarcoma (2004) (43)
FISH identifies different types of duplications with 12q13‐15 as the commonly involved segment in B‐cell lymphoproliferative malignancies characterized by partial trisomy 12 (1997) (43)
Interphase cytogenetics of the t(8;21)(q22;q22) associated with acute myelogenous leukemia by two-color fluorescence in situ hybridization. (1995) (43)
Recombinant hematopoietic growth factors fail to induce a proliferative response in precursor B acute lymphoblastic leukemia. (1989) (43)
Acral myxoinflammatory fibroblastic sarcoma with unique clonal chromosomal changes (2001) (43)
Localization of the human c-sis oncogene in Ph1-positive and Ph1-negative chronic myelocytic leukemia by in situ hybridization. (1984) (42)
Translocation (8;17;15;21)(q22;q23;q15;q22) in acute myeloid leukemia (M2). a four-way variant of t(8;21). (2001) (41)
AMLI fusion transcripts in t(3;21) positive leukemia: Evidence of molecular heterogeneity and usage of splicing sites frequently involved in the generation of normal AMLI transcripts (1994) (41)
Systematic screening at diagnosis of -5/del(5)(q31), -7, or chromosome 8 aneuploidy by interphase fluorescence in situ hybridization in 110 acute myelocytic leukemia and high-risk myelodysplastic syndrome patients: concordances and discrepancies with conventional cytogenetics. (2004) (41)
Cytogenetic follow-up of patients with nonlymphocytic leukemia I. Philadelphia chromosome-positive chronic myeloid leukemia☆ (1980) (40)
Clinical, cytogenetic and molecular characteristics of 14 T-ALL patients carrying the TCRβ-HOXA rearrangement: a study of the Groupe Francophone de Cytogénétique Hématologique (2007) (40)
The translocation (6;9) (p23;q34) shows consistent rearrangement of two genes and defines a myeloproliferative disorder with specific clinical features. (1992) (40)
Localization of genes on human chromosomes by studies of human-Chinese hamster somatic cell hybrids (1973) (40)
Partial trisomy 21 (1977) (39)
Complex genomic rearrangement of ALK loci associated with integrated human Epstein-Barr virus in a post-transplant myogenic liver tumor. (2003) (39)
Is there a difference in childhood T-cell acute lymphoblastic leukaemia and T-cell lymphoblastic lymphoma? (2007) (39)
MLL amplification in myeloid leukemias: A study of 14 cases with multiple copies of 11q23. (2000) (39)
Activity and safety of combined rituximab with chlorambucil in patients with mantle cell lymphoma (2005) (39)
A physical, transcript, and deletion map of chromosome region 12p12.3 flanked by ETV6 and CDKN1B: hypermethylation of the LRP6 CpG island in two leukemia patients with hemizygous del(12p). (1999) (38)
Loss and gain of chromosomes 1, 18, and Y in prostate cancer (1994) (37)
Dek-can rearrangement in translocation (6;9)(p23;q34). (1992) (36)
Characterization of the Philadelphia chromosome by gene mapping. (1981) (36)
Is 4q13 a recurring breakpoint in solitary fibrous tumors? (2001) (36)
Human ovarian tumors of epithelial origin express PDGF in vitro and in vivo. (1994) (36)
Chromosome abnormalities in CML. (1987) (35)
Gain and loss of chromosomes 1, 7, 8, 10, 18, and Y in 46 prostate cancers. (1996) (35)
Fusion of EML 1 to ABL 1 in T-cell acute lymphoblastic leukemia with cryptic t ( 9 ; 14 ) ( q 34 ; q 32 ) (2005) (35)
CIZ gene rearrangements in acute leukemia: report of a diagnostic FISH assay and clinical features of nine patients (2005) (34)
Use of dual-color interphase FISH for the detection of inv(16) in acute myeloid leukemia at diagnosis, relapse and during follow-up: a study of 23 patients (2000) (34)
Cytogenetic analysis of human renal carcinoma cell lines of common origin (NC 65). (1979) (34)
Acute myeloid leukemia M4 with bone marrow eosinophilia (M4Eo) and inv(16)(p13q22) exhibits a specific immunophenotype with CD2 expression. (1993) (34)
Genomic acute myeloid leukemia-associated inv(16)(p13q22) breakpoints are tightly clustered (1999) (33)
Application of the International Prognostic Scoring System for myelodysplastic syndromes. (1999) (33)
Heterogeneity of BCL6 rearrangements in nodular lymphocyte predominant Hodgkin's lymphoma. (2004) (33)
Multicolor COBRA‐FISH analysis of chronic myeloid leukemia reveals novel cryptic balanced translocations during disease progression (2002) (32)
Acute myeloid leukemias with chromosomal abnormalities involving the 21q22 region identified by their in vitro responsiveness to interleukin-5. (1991) (32)
Genomic characterization of MOZ/CBP and CBP/MOZ chimeras in acute myeloid leukemia suggests the involvement of a damage‐repair mechanism in the origin of the t(8;16)(p11;p13) (2003) (32)
Cryptic t(4;11) encoding MLL-AF4 due to insertion of 5′ MLL sequences in chromosome 4 (2001) (32)
Identical fusion transcript associated with different breakpoints in the AML1 gene in simple and variant t(8;21) acute myeloid leukemia. (1995) (31)
A gene for a myosin peptide is disrupted by the inv(16)(p13q22) in acute nonlymphocytic leukemia M4Eo (1993) (31)
Cytogenetic clonality analysis: typical patterns in myelodysplastic syndrome and acute myeloid leukaemia (1996) (31)
A non-random chromosome abnormality found in precursor-B lineage acute lymphoblastic leukaemia: dic(9;20)(p1?3;q11). (1995) (31)
Simple monosomy 7 and myelodysplastic syndrome in thirteen patients without previous cytostatic treatment (1986) (31)
Additional c-abl/bcr rearrangements in a CML patient exhibiting two ph1 chromosomes during blast crisis. (1986) (31)
Lipoblastoma and lipoblastomatosis (2006) (31)
Translocation (6;9) may be associated with a specific TdT-positive immunological phenotype in ANLL. (1988) (30)
Richter's syndrome with identical immunoglobulin gene rearrangements in the chronic lymphocytic leukemia and the supervening non-Hodgkin lymphoma. (1989) (29)
The idic(X)(q13) in myeloid malignancies: breakpoint clustering in segmental duplications and association with TET2 mutations. (2010) (28)
Detection of Minimal Residual Disease in TdT Positive T Cell Malignancies by Double Immunofluorescence Staining (1984) (28)
Translocation t(2;3)(p15–23;q26–27) in myeloid malignancies: report of 21 new cases, clinical, cytogenetic and molecular genetic features (2004) (28)
FISH identifies different types of duplications with 12q13-15 as the commonly involved segment in B-cell lymphoproliferative malignancies characterized by partial trisomy 12. (1997) (28)
Myelodysplastic syndrome with monosomy 5 and/or 7 following therapy with 2‐chloro‐2′‐deoxyadenosine (1999) (28)
Translocation t(1;6)(p35.3;p25.2): a new recurrent aberration in ‘unmutated’ B-CLL (2005) (27)
DMSO-induced terminal differentiation and trisomy 15 in myeloid cell line transformed by the Rauscher murine leukemia virus. (1981) (27)
Isochromosome 17 q in Blast Crisis of Chronic Myeloid Leukemia and in Other Hematologic Malignancies Is the Result of Clustered Breakpoints in 17 p 11 and Is Not Associated With Coding TP 53 Mutations (1999) (26)
The effects of interleukin-3, GM-CSF, and G-CSF on the growth kinetics of colony-forming cells in myelodysplastic syndromes. (1990) (26)
The Human C/EBPδ (CRP3/CELF) Gene: Structure and Chromosomal Localization (1993) (26)
Translocation (3;21) in Philadelphia positive chronic myeloid leukemia: high resolution chromosomal analysis and immunological study on five new cases. (1989) (26)
Clonality analysis of hematopoietic cell lineages in acute myeloid leukemia and translocation (8;21): only myeloid cells are part of the malignant clone (1997) (26)
A novel recurrent translocation t(11;14)(p11;q32) in splenic marginal zone B cell lymphoma (2001) (25)
A new B-cell line showing a complex translocation (8;14;18) and BCL2 rearrangement. (1994) (25)
EVI1 overexpression in t(3;17) positive myeloid malignancies results from juxtaposition of EVI1 to the MSI2 locus at 17q22 (2008) (25)
Chromosomal localization of three repair genes: the xeroderma pigmentosum group C gene and two human homologs of yeast RAD23. (1994) (25)
Endometrial stromal sarcoma with a sole t(X;17) chromosome change: report of a case and review of the literature. (2003) (25)
Construction of human-mouse T cell hybrids that express human T cell-associated surface antigens and allow the chromosomal localization of these antigens. (1986) (25)
TdT positive B‐cell acute lymphoblastic leukaemia (B‐ALL) without Burkitt characteristics (1988) (25)
Coexistence of BCL1/CCND1 and CMYC aberrations in blastoid mantle cell lymphoma: a rare finding associated with very poor outcome (2004) (25)
Common chromosome aberrations in the proximal type of epithelioid sarcoma. (2000) (25)
Calcifying/ossifying synovial sarcoma shows t(X;18) with SSX2 involvement and mitochondrial calcifications (2001) (25)
Characterization of three human malignant mesothelioma cell lines. (1989) (25)
In vitro-induced resistance to the deoxycytidine analogues cytarabine (AraC) and 5-aza-2′-deoxycytidine (DAC) in a rat model for acute myeloid leukemia is mediated by mutations in the deoxycytidine kinase (dck) gene (1995) (25)
Specific cytogenetic aberrations in two novel human prostatic cell lines immortalized by human papillomavirus type 18 DNA. (1997) (25)
Genomic organization and chromosomal localization of the human CD27 gene. (1992) (24)
The human pim-1 gene is not directly activated by the translocation (6;9) in acute nonlymphocytic leukemia. (1989) (24)
Acute myeloid leukaemia with +i(12p) shortly after treatment of mediastinal germ cell tumour (1994) (24)
Development of an interphase fluorescent in situ hybridization (FISH) test to detect t(8;21) in AML patients (1998) (23)
An in vitro model for cytogenetic conversion in CML. Interferon-alpha preferentially inhibits the outgrowth of malignant stem cells preserved in long-term culture. (1998) (23)
FISH identifies inv(16)(p13q22) masked by translocations in three cases of acute myeloid leukemia (1998) (23)
Cytogenetic characterization of an established xenografted prostatic adenocarcinoma cell line (PC-82). (1988) (21)
Trisomy 11 in myeloid malignancies is associated with internal tandem duplication of both MLL and FLT3 genes. (2005) (21)
Patterns of genomic aberrations suggest that Burkitt lymphomas with complex karyotype are distinct from other aggressive B‐cell lymphomas with MYC rearrangement (2013) (21)
Localization of human myeloid-associated surface antigen detected by a panel of 20 monoclonal antibodies to the q12-qter region of chromosome 11. (1984) (20)
Angiomyxolipoma shares cytogenetic changes with lipoma, spindle cell/pleomorphic lipoma and myxoma (2000) (20)
Expression of the ETS2 and transferrin receptor genes in Philadelphia‐positive chronic myeloid leukemia patients with a reciprocal t(3;21) (1992) (20)
CDKN2 gene deletion is not found in chronic lymphoid leukaemias of B‐ and T‐cell origin but is frequent in acute lymphoblastic leukaemia (1995) (20)
Four aged siblings with B cell chronic lymphocytic leukemia (1997) (20)
Cytogenetic analysis of 39 prostate carcinomas and evaluation of short-term tissue culture techniques. (1998) (20)
Serological and Biochemical Characterization of Human Myeloid-Associated Antigens and Their Expression in Human-Mouse Cell Hybrids (1984) (20)
Bivariate flow karyotyping of acute myelocytic leukemia in the BNML rat model. (1987) (19)
Cytogenetic and molecular studies of the Philadelphia translocation t(9;22) observed in a patient with myelodysplastic syndrome. (1989) (19)
Complex Genetic Alterations in Gastrointestinal Stromal Tumors with Autonomic Nerve Differentiation (2002) (19)
The use of FISH with chromosome-specific repetitive DNA probes for the follow-up of leukemia patients. Correlations and discrepancies with bone marrow cytology. (1996) (18)
Chromosomal gains and losses are uncommon in hairy cell leukemia: a study based on comparative genomic hybridization and interphase fluorescence in situ hybridization. (2001) (18)
The invasion-inducing TIAM1 gene maps to human chromosome band 21q22 and mouse chromosome 16. (1995) (18)
Cytogenetic findings in mouse multiple myeloma and Waldenström's macroglobulinemia. (1996) (18)
Interphase fluorescence in situ hybridization on selected plasma cells is superior in the detection of cytogenetic aberrations in plasma cell dyscrasia (2010) (18)
Myeloma isotype-switch variants in the murine 5T myeloma model: evidence that myeloma IgM and IgA expressing subclones can originate from the IgG expressing tumour (2001) (17)
Regional localization of aβ-galactosidase locus on human chromosome 22 (1977) (17)
Translocation (16;21)(p11;q22) in acute monoblastic leukemia with erythrophagocytosis. (1991) (17)
The value of interphase fluorescence in situ hybridization for the detection of translocation t(12;21) in childhood acute lymphoblastic leukemia (2000) (17)
Familial balanced insertion (5;10) and monosomy and trisomy (10) (q24.2→q25.3) (1984) (16)
Molecular and cytogenetic abnormalities in acute myeloid leukaemia and myelodysplastic syndromes. (1996) (16)
T-lymphoblastic lymphoma terminating as malignant histiocytosis with rearrangement of immunoglobulin heavy chain gene. (1991) (16)
A gene for a myosin peptide is disrupted by the inv(16)(p13q22) in acute nonlymphocytic leukemia M4Eo. (1993) (16)
Localization of the HST/FGFK gene with regard to 11 q 13 chromosomal breakpoint and fragile site (1991) (16)
A complex t(3;8;17) involving breakpoint 8p11 in a case of M5 acute nonlymphocytic leukemia with erythrophagocytosis. (1989) (16)
Proceedings: The human loci for phosphopyruvate hydratase and guanylate kinase are syntenic with the PGD-PGM1 linkage group in man-Chinese hamster somatic cell hybrids. (1974) (16)
Proceedings: Evidence for synteny between the human loci for triose phosphate isomerase, lactate dehydrogenase-B, and peptidase-B and the regional mapping of these loci on chromosome 12. (1974) (16)
Analysis of the P53, RB/D13S25, and P16 tumor suppressor genes in marginal zone B-cell lymphoma: An interphase fluorescence in situ hybridization study. (2000) (15)
Fusion of ETV6 to GOT1 in a case with myelodysplastic syndrome and t(10;12)(q24;p13). (2006) (15)
Decreased tumorigenicity of rodent cells after fusion with leukocytes from normal and leukemic donors (1981) (15)
Two new translocations involving the 11q23 region map outside the MLL locus in myeloid leukemias. (2002) (15)
The Philadelphia chromosome as a secondary abnormality in two cases of acute myeloid leukemia (1998) (15)
Philadelphia-negative acute lymphoblastic leukemia developing in a CML patient in imatinib mesylate-induced complete cytogenetic remission (2003) (15)
Positional mapping of loci in the DiGeorge critical region at chromosome 22q11 using a new marker (D22S183) (1995) (15)
C‐Group Chromosome Abnormalities in Bone Marrow Cells of Three Children with Dyshaematopoiesis of Unknown Origin (1980) (14)
Trisomy 3q11-q29 is recurrently observed in B-cell non-Hodgkin's lymphomas associated with cold agglutinin syndrome (1998) (14)
Intracranial germ cell tumour (embryonal carcinoma with teratoma) with complex karyotype including isochromosome 12p (1998) (14)
Monosomal karyotype and chromosome 17p loss or TP53 mutations in decitabine-treated patients with acute myeloid leukemia (2020) (14)
Characterization of clonogenic cells in refractory anemia with excess of blasts (RAEB-CFU): response to recombinant hematopoietic growth factors and maturation phenotypes. (1989) (14)
Two‐colour FISH detection of the inv(16) in interphase nuclei of patients with acute myeloid leukaemia (1999) (14)
Regional localization of the human c-rel locus using translocation chromosome analysis. (1988) (14)
Fourth International Workshop on Chromosomes in Leukemia 1982: Translocation (8;21)(q22;q22) in acute nonlymphocytic leukemia. (1984) (13)
Density profiles and purification of chronic myeloid leukemia cells forming colonies in the PHA-leukocyte feeder assay. (1981) (13)
Efficient long-term maintenance of chronic myeloid leukemic cobblestone area forming cells on a murine stromal cell line (1997) (13)
Constitutional DNA‐level aberrations in chromosome 22 in a patient with multiple meningiomas (1994) (12)
Studies on chronic myeloid leukemia cell populations with colony-forming abilities in PHA-leukocyte feeder and Robinson assays. (1982) (12)
Human solid tumors: cytogenetic techniques. (2003) (12)
Influence of Karyotype On Overall Survival in Patients with Higher-Risk Myelodysplastic Syndrome Treated with Azacitidine or a Conventional Care Regimen. (2009) (12)
Regional mapping of TPI, LDH-B, and Pep-B on chromosome 12 of man. (1975) (12)
Trisomy 15 and other nonrandom chromosome changes in Rauscher murine leukemia virus-induced leukemia cell lines. (1982) (12)
High numbers of mobilized CD34+ cells collected in AML in first remission are associated with high relapse risk irrespective of treatment with autologous peripheral blood SCT or autologous BMT (2015) (12)
Spindle-cell rhabdomyosarcoma with 2q36∼q37 involvement (2003) (12)
Impact of induction regimen and allogeneic hematopoietic cell transplantation on outcome in younger adults with acute myeloid leukemia with a monosomal karyotype (2018) (11)
Clonal origin of the Philadelphia translocation in chronic myeloid leukemia demonstrated in somatic cell hybrids using an adenylate kinase-1 polymorphism. (1982) (11)
The 5a-chromosome abnormality in haematological disorders: a collaborative study of 34 cases from the Netherlands. (1982) (11)
Identification of chromosome changes in acute myeloid leukemia (AML-M2) by molecular cytogenetics. (1997) (11)
12p chromosomal aberrations in precursor B childhood acute lymphoblastic leukemia predict an increased risk of relapse in the central nervous system and are associated with typical blast cell morphology. (1994) (11)
Assignment of the leucocyte group five surface antigens to human chromosome 4. (2008) (11)
Prognostic significance of karyotype at diagnosis in childhood acute lymphoblastic leukemia [corrected]. (1992) (10)
An inv(16)(p13q22) positive acute myeloid leukaemia relapsing as acute precursor B-cell lymphoblastic leukaemia. (2004) (10)
MLL-AF6 fusion resulting from a new three-way translocation t(6;11;7) in a patient with acute myeloid leukemia (2001) (10)
Phagocytic plasma cells in a patient with multiple myeloma. (1995) (10)
The combined effects of Il-3, GM-CSF and G-CSF on the in vitro growth of myelodysplastic myeloid progenitor cells. (1990) (10)
Localization of Gene Markers to Regions of the Human X Chromosome by Segregation of X-Autosome Translocations in Somatic Cell Hybrids (1974) (10)
Hydrocortisone-induced increase of PDGF beta-receptor expression in a human malignant mesothelioma cell line. (1992) (10)
The prognostic significance of chromosomal findings in patients with acute myeloid leukemia in a study comparing the efficacy of autologous and allogeneic bone marrow transplantation. (1991) (9)
Fusion of ETV 6 to MDS 1 / EVIJ as a Result of t ( 3 ; 12 ) ( q 26 ; p 13 ) in Myeloproliferative Disorders (2006) (9)
Characterization of chromosome 8 aberrations in the prostate cancer cell line LNCaP-FGC and sublines (1999) (9)
Genomic organization of the translocations (8;14) and (14;18) in a new lymphoma cell line. (1994) (9)
Imatinib mesylate induces durable complete remission of advanced CML persisting after allogeneic bone marrow transplantation (2003) (9)
Cytogenetic abnormalities in Waldenstrom's disease (WD): A single centre study on 45 cases. (1998) (9)
Clinical relevance of cytogenetics in acute leukemia. (1990) (9)
Cytogenetic and molecular characterization of a masked Philadelphia chromosome in chronic myelocytic leukemia. (1987) (9)
Screening for EVI1: ectopic expression absent in T-cell acute lymphoblastic leukemia patients and cell lines. (2006) (8)
Validation of an interphase fluorescence in situ hybridization approach for the detection of MLL gene rearrangements and of the MLL/AF9 fusion in acute myeloid leukemia. (2006) (8)
An infant with an XXXYY karyotype (1974) (8)
In myelodysplastic syndromes progression to leukemia is directly related to PHA dependency for colony formation and independent of in vitro maturation capacity. (1988) (8)
Human formaldehyde dehydrogenase (FDH) and its assignment to chromosome 4. (1984) (8)
Unique clinical features and prognostic significance of the translocation (6;11) in acute leukemia. (1993) (8)
Fibrous dysplasia and the short arm of chromosome 12 (1999) (8)
Mapping the Xga red blood cell antigen in human-Chinese hamster cell hybrids. The Xg locus is possibly located on the short arm of the X chromosome. (1975) (8)
New Possibilities for Cytogenetic Analysis of Leukemic Cells (1986) (8)
ACUTE LYMPHOBLASTIC LEUKAEMIA OCCURRING 6 YEARS AFTER TREATMENT OF HODGKIN'S DISEASE (1988) (7)
Early diagnosis of smoldering acute lymphoblastic leukemia using immunological marker analysis. (1993) (7)
Deletion of the inositide-specific phospholipase c β1 gene is a rare event in myelodysplastic syndrome and thus of limited value to predict leukemic progression (2005) (7)
Trisomy 16 as the sole anomaly in hematological malignancies. Three new cases and a short review. (2001) (7)
Multiple myeloma and acute megakaryoblast leukemia in spent phase polycythemia vera. (1990) (7)
Localization of the oncogene c-Ha-ras1 outside the aniridia-Wilms' tumor-associated deletion of chromosome 11(del 11p13) using somatic cell hybrids. (1985) (7)
Integrative study of EZH2 mutational status, copy number, protein expression and H3K27 trimethylation in AML/MDS patients (2019) (7)
Simple method for detection of MYH11 DNA rearrangements in patients with inv(16)(p13q22) and acute myeloid leukemia. (1996) (7)
Report of the International Meeting on Chromosome 12 Genes in Cancer. (1996) (6)
Mapping the Xga red blood cell antigen in human-Chinese hamster cell hybrids. The Xg locus is possibly located on the short arm of the X chromosome. (1975) (6)
Simultaneous occurrence of acute monoblastic leukemia and an abnormal B-cell clone with both cell types characterized by specific cytogenetic and immunological markers. (2009) (6)
Update of the cytogenetic study of childhood non-high-risk acute lymphocytic leukemia at diagnosis in protocol VI of the Dutch Childhood Leukemia Study Group. (1990) (6)
Mobilisation of haemopoietic progenitors in CML: a second course of intensive chemotherapy does not improve Ph-negativity in stem cell harvests (2000) (6)
Spindle-cell rhabdomyosarcoma with 2q36 approximately q37 involvement. (2003) (5)
Acute myelogenous leukemia: a disorder of gene splicing? (1996) (5)
The human C/EBP delta (CRP3/CELF) gene: structure and chromosomal localization. (1993) (5)
Deletion of chromosome 15 represents a rare but recurrent chromosomal abnormality in myelocytic malignancies. (2003) (5)
Deletion of chromosome 15 represents a rare but recurrent chromosomal abnormality in myelocytic malignancies (2003) (5)
Ring chromosome 6 may represent a cytogenetic subgroup in benign thymoma. (2002) (5)
Acute Myeloid Leukemia M 4 With Bone Marrow Eosinophilia ( M 4 Eo ) and inv ( 16 ) ( p 13 q 22 ) Exhibits a Specific Immunophenotype With CD 2 Expression (2003) (5)
Fusion of NUP214 to ABL1 on amplified extrachromosomal elements in T-ALL. (2004) (4)
The Philadelphia translocation in CML and ALL: recent investigations, new detection methods. (1990) (4)
Expression of chronic myeloid leukaemia-associated changes in membrane glycopeptides in somatic cell hybrids. (1981) (4)
Role of interleukin-7 in the growth of acute lymphoblastic leukemia. (1990) (4)
Leukemic karyotype in CFU-C of a patient with acute myelomonocytic leukemia. (1983) (4)
Production of Human T-Cell Hybridomas by Electrofusion (1985) (4)
Acute megakaryoblastic leukemia and loss of the RUNX1 gene. (2006) (4)
Cloning of a putative meningioma tumor suppressor gene (1994) (4)
Cytogenetics and oncogenes. (1992) (4)
Establishment and characterization of human normal and malignant mesothelial cell lines (1994) (4)
Translocation (5p; 17q) in blast crisis of chronic myeloid leukemia. (1981) (4)
Isolation, properties and chromosomal localization of four closely linked hamster interferon-alpha-encoding genes. (1995) (4)
Molecular characterization of a t(2;3)(p23;q26): A recurrent translocation involving the EVI1 gene (2001) (3)
Selective hybrid cell formation by human lymphoid cells (1973) (3)
In vitro growth kinetics of myeloid progenitor cells of myelodysplastic patients in response to granulocyte-macrophage colony-stimulating factor and interleukin-3. (1990) (3)
FOXP1, a highly expressed gene in a subset of DLBCL, is targeted by a recurrent t(3;14)(p13;q32) (2004) (3)
Low-Dose Decitabine Vs Best Supportive Care In Older Patients With AML and Low Blast Counts: Results Of a Subgroup Analysis Of The Randomized Phase III Study 06011 Of The EORTC Leukemia Cooperative Group and German MDS Study Group (2013) (3)
Late-replicating ring X-chromosomes identified by r-banding after BrdU pulse (1976) (3)
P052 Acquired mutations in TET2 are common in myelodysplastic syndromes (2009) (3)
Human Meningioma Cells by Recombinant Interferon-a (1991) (3)
Cytogenetic clonal heterogeneity is not an independent prognosis factor in 15–60-year-old AML patients: results on 1291 patients included in the EORTC/GIMEMA AML-10 and AML-12 trials (2018) (3)
Novel CBFB-MYH11 fusion transcripts or reverse transcription-polymerase chain reaction artifacts? (1996) (3)
Localization of sequences related to the human RAD6 DNA repair gene on mouse Chromosomes 11 and 13 (1995) (3)
Characterization of a complex philadelphia translocation (1p-;9q+;22q-) by gene mapping (2004) (3)
Fourth International Workshop on Chromosomes in Leukemia 1982: Chromosomes in acute promyelocytic leukemia. (1984) (3)
Will a Peripheral Blood (PB) Sample Yield the Same Diagnostic and Prognostic Cytogenetic Data as the Concomitant Bone Marrow (BM) In Myelodysplasia? An International Study Comparing Cytogenetics and Interphase FISH Using Parallel PB and BM Samples (2010) (3)
73 Cytogenetic characterization of androgen-responsive and -unresponsive sublines of the human prostatic carcinoma cell line LNCAP (1989) (3)
Cytogenetic analysis in three cerebral subependymomas: further evidence for a hamartomatous nature? (2000) (3)
Trisomy 13 in myeloid malignancies: Clinical, morphologic and immunologic correlations and characterization by combined immunophenotyping and interphase fluorescence in situ hybridization (FISH). (1996) (3)
In situ hybridization with a chromosome 1 specific DNA probe on interphase nuclei from prostate cancer cells. (1991) (2)
Insertion (4;11)(q27;q24q21) in a patient with essential thrombocythemia with progression to myelofibrosis. (2004) (2)
133 Expression of the PDGF B- (c-cis) and PDGF A-chain genes and the PDGF B-type receptor in human malignant mesothelioma cell lines (1989) (2)
ENDOMETRIAL STROMAL SARCOMA WITH A SOLE T(X;17) CHROMOSOME CHANGE (2003) (2)
Monosomy 7 syndrome hematologic and cytogenetic course in 2 children (1985) (2)
Expression of the human immunoglobulin heavy chain gene of the 14q+ chromosome in a t(8;14)-positive Burkitt lymphoma cell line demonstrated in somatic cell hybrids. (1986) (2)
Decreased tumorigenicity of Chinese hamster cells after fusion with tumorigenic mouse myeloid leukemia cells. (1982) (2)
Analysis of the breakpoints in translocation (15;17) Observed in 4 patients with acute promyelocytic leukemia (1982) (2)
The c-abl oncogene in chronic myelogenous leukemia. (1987) (2)
Characterization of a rat oral squamous cell carcinoma cell line UHG-RaC '93 induced by 4-nitroquinoline-1-oxide in vivo. (1995) (2)
New possibilities for cytogenetic analysis (1986) (2)
Cytogenetics and Cell Genetics (1986) (2)
Regional mapping of TPI, LDH-B, Pep-B on chromosome 12 of man. (1975) (2)
A multicenter phase II trial of Decitabine as first-line treatment of older patients with acute myeloid leukemia judged unfit for induction chemotherapy Running head: First-line DAC for older AML patients unfit for induction (2011) (1)
Acute Monoblastic Leukemia with Erythrophagocytosis (1991) (1)
Multicolor fluorescence in situ hybridization (M-FISH) in highly aggressive B-cell lymphomas with 8q24/MYC involvement revealed the heterogeneity of 13q abnormalities with unexpected partial gains. (2006) (1)
Characterization of Nup214-abl1 Positive T-cell Acute Lymphoblastic Leukemia Reveals Genomic Heterogeneity of the Fusion Gene Presentation (2008) (1)
Characterization and Monitoring of the Malignant Cells in the Elastic and Chronic Phase of Chronic Myeloid Leukemia (1984) (1)
NOTCH1 Is Targeted by Ig Translocations in NHL. (2005) (1)
Integrative study of EZH2 mutational status, copy number, protein expression and H3K27 trimethylation in AML/MDS patients (2021) (1)
The T(14;20)(Q32;Q12): A rare cytogenetic change in MM associated with poor outcome (2007) (1)
Amplification of chromosome 11q23 involving the MLL gene is recurrently observed in myeloid leukemias. (1998) (1)
Distinct oncogenic properties of NUP214-ABL1 in T-cell acute lymphoblastic leukemia (2005) (1)
Patients with myelodysplastic syndrome and two clones with different interstitial deletions of the long arm of chromosome 5 (2013) (1)
Positional mapping of loci in the DiGeorge critical region at chromosome 22 q l l using a new marker ( D 22 S 183 ) (2003) (1)
Involvement of the Notch1 and Notch2 genes in B-cell lymphomagen (2006) (1)
Allogeneic SCT planned in CR-1 after intensive chemotherapy in patients with bad prognosis MDS results in better outcome in the intermediate/high-risk cytogenetic group: a study by the EORTC, EBMT, SAKK, HOVON and GIMEMA Leukemia Groups (2006) (1)
Specific chromosomal abnormalities in acute monoblastic leukemia. (1982) (1)
Positional mapping of loci in the DiGeorge critical region at chromosome 22 q l l using a new marker ( D 22 S 183 ) (2003) (1)
A family with a 17p: pericentric inversion: implications for carriers (Olgu Sunumu) (2004) (1)
Spontaneous Hybridization of Human Leukocytes With a 3T3 (TK-) Mouse Cell Line (1970) (1)
P66: Identification of genes involved in T-cell oncogenesis through FISH screening of TCR rearrangements in T-ALL (2005) (1)
[The Philadelphia chromosome, 25 years later. 1960-1985]. (1985) (1)
Coexistence of light chain disease and chronic lymphocytic leukaemia, a complex karyotype with a rapid fatal outcome. (2006) (1)
The genetic profile of marginal zone B-cell lymphoma (1999) (0)
In situ hybridization of two human somatostatin receptor genes (SSTR1 & 2) in breast carcinoma cell lines and allelic imbalance of these two genes in human primary breast tumours (1994) (0)
Oncogenes and Chromosomal Aberrations (1986) (0)
leukemia (BCP-ALL) translocations in B-cell precursor acute lymphoblastic IGH recurrent transcription factor family are targeted by CEBP Five members of the (2011) (0)
Oncogenes and cancer monitoring (1991) (0)
Confirmation of the assignment of the gene coding for the BA-2 antigen to human chromosome 12 (2004) (0)
rearrangements leukemia distinguishes cases with underlyingPLZF/RARA gene A new morphologic classification system for acute promyelocytic (2013) (0)
Outcome of Older AML Patients with Adverse Cytogenetics, Including Single or Multiple Monosomies, Treated with the DNA Hypomethylating Agent Decitabine (2011) (0)
The TCRB-HOXA rearrangement in T-ALL leads to a specific increase of the alternative HOXA10b transcript (2006) (0)
Claes Lundsteen—in Memoriam (2004) (0)
The add(1)(p36)-associated commonly lost region in lymphoma maps within the terminal 1 Mb region of 1p. (2002) (0)
Short communication Chromosomal gains and losses are uncommon in hairy cell leukemia: a study based on comparative genomic hybridization and interphase fluorescence in situ hybridization (2001) (0)
Intensive chemotherapy versus autologous or allogeneic stemcell transplantation for the treatment of patients with poor risk MDS and secondary AML-A joint study of the Eortc, Ebmt, Hovon, Swiss, Scandinavian and Gimema leukemia groups: A biomed-2 EU-project. (1999) (0)
negative chronic myelocytic leukemia by in situ hybridization Localization of the human c-sis oncogene in Ph1-positive and Ph1- (2011) (0)
Book Review Inherited Susceptibility to Cancer: Clinical, predictive and ethical perspectives Edited by William D. Foulkes and Shirley V. Hodgson. 456 pp. New York, Cambridge University Press, 1998. $95. 0-521-56340-2 (1999) (0)
Clonal chromosomal abnormalities in Ph-negative cells in chronic myeloid leukemia: an unusual case evolving to secondary acute myeloid leukemia. (2015) (0)
No chromosome arm unturned: in memory of Roland Berger 1934–2012 (2014) (0)
in CD34+ acute myeloid leukemia cells Predominance of functional multidrug resistance (MDR-1) phenotype (2011) (0)
Expression of c-sis in human malignant mesothelioma cell lines (1987) (0)
Implementation of Standardized International Karyotype Scoring Practices Is Needed to Provide Uniform and Systematic Evaluation for Patients with Myelodysplastic Syndrome Using IPSS Criteria: An International Working Group on MDS Cytogenetics Study (2008) (0)
Fluorescence In Situ Hybridization (FISH): A Powerful Method for the Detection of Genetic Abnormalities in Metaphases and in Interphase Nuclei (1999) (0)
EORTC Leukemia Group achievements (2012) (0)
gene consistently fuses the leucine zipper motif of AF10 onto the HRX The t(10;11) translocation in acute myeloid leukemia (M5) (2011) (0)
Burkitt's lymphoma-associated translocations in multiple myeloma and plasma cell leukemia (1998) (0)
[Chromosome abnormalities in leukemia in children. Occurrence and clinical significance]. (1982) (0)
Coexistence of myelodysplastic syndromes and plasma cells disorders. a cytogenetic review (2010) (0)
The impact of post-remission therapy on outcome of patients with poor risk MDS and secondary AML (sAML) treated with intensive chemotherapy with or without stem cell transplantation in a joint study (2004) (0)
Subject Index Vol. 30, 1981 (1981) (0)
124 Cytogenetic analysis of malignant mesotheliomas (1989) (0)
Cytogenetic Follow-up Studies of Patients with Acute Non-Lymphocytic Leukemia and Chronic Myeloid Leukemia (2008) (0)
Correction to: Integrative study of EZH2 mutational status, copy number, protein expression and H3K27 trimethylation in AML/MDS patients (2021) (0)
Ph1 chromosome: cytogenetics and molecular aspects (1987) (0)
The prognostic impact of cytogenetic features and clonality of patients with poor risk MDS and secondary AML (sAML) after treatment with intensive chemotherapy and stem cell transplantation for the treatment: a joint study oft he EORTCS, EBMT, SAK, HOVO (2001) (0)
Gene methylation and cytogenetic abnormalities in patients (pts) with higher-risk myelodysplastic syndromes. (2010) (0)
NF2 gene mutations in meningiomas and vestibular schwannomas (1994) (0)
Presence of unbalanced chromosomal translocations independently predicts for treatment failure, short treatment-free (TFS) and overall survival (OS) in B-cell chronic lymphocytic leukemia (B-CLL) patients treated with cladribine. (2006) (0)
Genetics-Expression of-human myeloid-associated surface antigens in human-mouse myeloid cell hybrids ( chronic myeloid leukemia / Philadelphia chromosome / monoclonal antibodies / chromosome 11 ) (2003) (0)
Contents, Vol. 30, 1981 (1981) (0)
Contents, Vol. 18, 1977 (1977) (0)
in determining the poor outcome observed in patients with trisomy 11. (2005) (0)
Impact of Induction Regimen and of Allogeneic Hematopoietic Cell Transplantation on the Outcome in Younger Adults Patients with Acute Myeloid Leukemia with a Monosomal Karyotype: Results from the EORTC/Gimema AML-10 and AML-12 Trials (2016) (0)
Proceedings: Localization of gene markers to regions of the human X chromosome by segregation of X-autosome translocations in somatic cell hybrids. (1974) (0)
Value of allogeneic stem cell transplantation (SCT) versus autologous SCT and chemotherapy in patients with myelodysplastic syndromes and secondary acute myeloid leukemia. Final results of a prospective randomized European Intergroup Trial (2010) (0)
O29: Detailed characterization of MYC-containing double minutes in hematologic malignancies: exclusion of MYC as the target gene and evidence in favor of an episome model in the genesis of dmin (2005) (0)
Dual color interphase FISH compared to RT-PCR and Southern blot for the detection of t(12;21) in childhood ALL (1998) (0)
Correction to: Integrative study of EZH2 mutational status, copy number, protein expression and H3K27 trimethylation in AML/MDS patients (2021) (0)
[Lesch-Nyhan syndrome. Heterozygote detection by biochemical selection of the mutant cells and autoradiography]. (1972) (0)
Characterization of two primary and two metastatic uveal melanoma cell lines (1993) (0)
Cytogenetic and molecular genetic analysis of primary tumours and cell lines indicate that mutation or deletion of the MTS-1 gene is a rare event in uveal melanoma (1996) (0)
RESULTS OF A CYTOGENETIC STUDY ON CHILDREN WITH NON-HIGH RISK ALL AT DIAGNOSIS IN PROTOCOL VI OF THE DUTCH CHILDHOOD LEUKEMIA STUDY-GROUP - (DCLSG) (1988) (0)
Translocation t(1;6)(p35.3;p25.2) Involves RCC1 and IRF4 and Is Not Restricted to Unmutated Chronic Lymphocytic Leukemia (2012) (0)
Chronic Myeloproliferative Neoplasms (2015) (0)
Acquired genetic changes in myeloid malignancies (2004) (0)
Prognostic value of translocations in B-CELL chronic lymphocytic leukemia (B-CLL) (2006) (0)
Consistent amplification of JAK2 in hematological malignancies with HSR(9)(P) (2000) (0)
References to the committee reports (1975) (0)
leukemia distinguishes cases with underlying A new morphologic classification system for acute promyelocytic (2000) (0)
A Gene for a Myos in Peptide Is Disrupted by the inv ( l 6 ) ( p 13 q 22 ) in Acute Nonlymphocytic Leukemia M 4 (2003) (0)
Interphase cytogenetics of prostate carcinoma (1992) (0)
Regional localization of a beta-galactosidase locus on human chromosome 22. (1977) (0)
Oral Sessions and Working Parties (2006) (0)
Human Genetic Mutant Cell Repository Index Vol. 18, 1977 (1977) (0)
A possible role for p16INK4 in malignant mesothelioma (1996) (0)
lymphoma predominance Hodgkin's lymphoma but not in classical Hodgkin's Frequent occurrence of BCL6 rearrangements in nodular lymphocyte (2013) (0)
In Childhood B-Lineage Acute Lymphoblastic Leukemia (B-ALL) with Hyperdiploidy >50 Chromosomes, Patients with 58 to 66 Chromosomes Have 99% EFS At 6-Year Follow-up: Results of the EORTC CLG 58951 Trial (2011) (0)
Decitabine (DAC) Vs. Best Supportive Care in Elderly Patients with Intermediate- and High-Risk MDS with or without Monosomal Karyotypes: Results of the EORTC-LG/German MDS-SG Randomized Phase III Trial 06011 (2012) (0)
P-277 Decitabine vs. best supportive care in elderly higher-risk MDS patients with or without monosomal karyotypes: EORTC-LG/GMDS-SG phase III trial 06011 (2013) (0)
Myeloid cell diff erentiation arrest by miR-125b-1 in myelodysplasic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation Most chromosomal translocations in myelodysplastic syndromes (MDS) (2008) (0)
Cytogenetics of 125 Untreated Patients with Binet Stages B or C B-CLL. Preliminary Results of a Multicentric Study from the French Cooperative Study Group on CLL. (2005) (0)
Molecular cytogenetic detection of loss or rearrangement of chromosome 22 in meningioma (1992) (0)
myeloid malignancies amplification and support an etiologic role for MLL gain of function in Expression analyses identify MLL as a prominent target of 11q23 (2013) (0)
Decitabine alone or in combination with ATRA: results of a phase II trial in 227 older medically non-fit AML patients, and a randomized, 4-arm follow-up study (DECIDER trial) (2012) (0)
Expression profile of survivin in acute leukaemias: the importance of differential splicing (2005) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Anne M. Hagemeijer?

Anne M. Hagemeijer is affiliated with the following schools:

Anne M. Hagemeijer's Academic­Influence.com Rankings

Why Is Anne M. Hagemeijer Influential?

Anne M. Hagemeijer's Published Works

Published Works

What Schools Are Affiliated With Anne M. Hagemeijer?

Anne M. Hagemeijer's AcademicInfluence.com Rankings